drugset / Trial / NCT02305693

Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS)

NCT02305693

Phase 3 Unknown 140 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

140 women with clomiphene resistant PCOS will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Letrozole, group 2 will have laparoscopic ovarian drilling (LOD).

Timeline

Start
2014-11
Primary completion
2017-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Letrozole Other / unclassified 2.5 mg Oral

Indications